ArticleJournal of obesity2026
Beneficial Effects of
Article in Journal of obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Butterfly pea flowers ( Objective: This study aimed to evaluate the effects of an herbal beverage composed of butterfly pea flowers and lemon fruits (BPL) on body weight (BW), Lee index (LI), body fat content (BFC), lipid profile (total cholesterol, low-density lipoprotein-cholesterol [LDL-C], high-density lipoprotein-cholesterol [HDL-C], and triglycerides [TGs]), leptin levels, and DPP4 activity in obese male Wistar rats. Methods: A pre- and post-test experimental design was conducted using 40 obese male Wistar rats, divided into five groups: NC (negative control, given 3 mL/day mineral water), positive control (PC, given 3 mL/day plant stanol ester), BPL1 received 3 mL/day BPL 75:25%, BPL2 received 3 mL/day BPL 80:20%, and BPL3 received 3 mL/day BPL 85:15%. All treatments were administered orally via gastric probe for 21 days. Data were analyzed using appropriate statistical tests to assess significant differences. Results: The BPL3 group showed the greatest reduction in BW and LI. The BPL1 group had the greatest reduction in TG levels, followed by the BPL3 group. The greatest reduction in leptin levels was found in the BPL2 group, followed by the BPL3 group. Conclusion: Oral administration of BPL herbal beverage with 85:15% formulation reduces BW and LI through the modulation of lipid metabolism and hormonal regulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.